Please use this identifier to cite or link to this item: https://doi.org/10.3389/fimmu.2018.00416
Title: Characterizing the role of monocytes in T cell cancer immunotherapy using a 3d microfluidic model
Authors: Lee, S.W 
Adriani, G
Ceccarello, E
Pavesi, A
Tan, A.T 
Bertoletti, A 
Kamm, R.D
Wong, S.C 
Keywords: programmed death 1 receptor
T lymphocyte receptor
Article
cancer immunotherapy
CD8+ T lymphocyte
cell aggregation
cell culture
cell expansion
cell interaction
cell isolation
controlled study
cytotoxic T lymphocyte
cytotoxicity assay
electroporation
flow cytometry
human
human cell
immunosuppressive treatment
impedance
microfluidic analysis
monocyte
peripheral blood mononuclear cell
protein expression
signal transduction
T lymphocyte activation
upregulation
Issue Date: 2018
Citation: Lee, S.W, Adriani, G, Ceccarello, E, Pavesi, A, Tan, A.T, Bertoletti, A, Kamm, R.D, Wong, S.C (2018). Characterizing the role of monocytes in T cell cancer immunotherapy using a 3d microfluidic model. Frontiers in Immunology 9 (MAR) : 416. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2018.00416
Abstract: In the hepatitis B virus (HBV)-related hepatocellular carcinoma tumor microenvironment (TME), monocytes reportedly impede natural T cell functions via PD-L1/PD-1 signaling. However, it remains unclear if T cell receptor-redirected T cells (TCR T cells) are similarly inhibited. Hence, we developed a 3D intrahepatic TME microfluidic model to investigate the immunosuppressive potential of monocytes toward HBV-specific TCR T cells and the role of PD-L1/PD-1 signaling. Interestingly, in our 3D static microfluidic model, we observed that monocytes suppressed only retrovirally transduced (Tdx) TCR T cell cytotoxicity toward cancer cells via PD-L1/PD-1, while mRNA electroporated (EP) TCR T cell cytotoxicity was not affected by the presence of monocytes. Importantly, when co-cultured in 2D, both Tdx and EP TCR T cell cytotoxicity toward cancer cells were not suppressed by monocytes, suggesting our 3D model as a superior tool compared to standard 2D assays for predicting TCR T cell efficacy in a preclinical setting, which can thus be used to improve current immunotherapy strategies. © 2018 Lee, Adriani, Ceccarello, Pavesi, Tan, Bertoletti, Kamm and Wong.
Source Title: Frontiers in Immunology
URI: https://scholarbank.nus.edu.sg/handle/10635/173736
ISSN: 16643224
DOI: 10.3389/fimmu.2018.00416
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fimmu_2018_00416.pdf3.44 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

22
checked on Nov 30, 2020

Page view(s)

24
checked on Dec 4, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.